State Medicaid programs must cover medication assisted treatment under a new mandatory benefit that takes effect today.

The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 added the benefit to increase access to evidenced-based treatment for opioid use disorder for Medicaid beneficiaries.

Specifically, states must cover all forms of drugs and biologicals that the Food and Drug Administration has approved or licensed for MAT to treat OUD, the Centers for Medicare & Medicaid Services said today in a reminder notice. 

 

Headline
The AHA commented Sept. 21 on the Centers for Medicare & Medicaid Services’ proposed rule to implement the changes to Medicaid provider tax policies that…
Headline
The AHA July 31 provided comments to the Centers for Medicare & Medicaid Services on its interim final rule on Medicaid community engagement requirements.…
Headline
The Centers for Medicare & Medicaid Services today released a proposed rule that would update Medicaid provider tax policies included in the July 2025…
Headline
The AHA provided comments July 21 to the Centers for Medicare & Medicaid Services on its proposed rule to modify policies governing Medicaid…
Headline
The Department of Homeland Security July 16 finalized its proposal to rescind the public charge ground of inadmissibility regulations issued in 2022. Among…
Headline
The Centers for Medicare & Medicaid Services July 7 released a bulletin announcing the end of its “fast-track” review process for certain Medicaid section…